Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Regulatory considerations for medical imaging AI/ML devices in the United States: concepts and challenges
29
Zitationen
8
Autoren
2023
Jahr
Abstract
FDA's AI/ML regulatory and scientific efforts support the joint goals of ensuring patients have access to safe and effective AI/ML devices over the entire device lifecycle and stimulating medical AI/ML innovation.
Ähnliche Arbeiten
Explainable Artificial Intelligence (XAI): Concepts, taxonomies, opportunities and challenges toward responsible AI
2019 · 8.200 Zit.
Stop explaining black box machine learning models for high stakes decisions and use interpretable models instead
2019 · 8.051 Zit.
High-performance medicine: the convergence of human and artificial intelligence
2018 · 7.416 Zit.
Proceedings of the 19th International Joint Conference on Artificial Intelligence
2005 · 5.776 Zit.
Peeking Inside the Black-Box: A Survey on Explainable Artificial Intelligence (XAI)
2018 · 5.410 Zit.